0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Biologics Drug Discovery Market Research Report 2025
Published Date: September 2025
|
Report Code: QYRE-Auto-0D6239
Home | Market Reports | Business & Industrial| Pharmaceuticals & Biotech
Global and United States Biologics Drug Discovery Market Report Forecast 2022 2028
BUY CHAPTERS

Global Biologics Drug Discovery Market Research Report 2025

Code: QYRE-Auto-0D6239
Report
September 2025
Pages:87
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES

Biologics Drug Discovery Market Size

The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years.

Biologics Drug Discovery Market

Biologics Drug Discovery Market

The global market for Biologics Drug Discovery was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
The biologics drug discovery involves target identification, hit-to-lead stage, lead identification and optimization.
The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for Biologics Drug Discovery, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Biologics Drug Discovery.
The Biologics Drug Discovery market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Biologics Drug Discovery market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Biologics Drug Discovery companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation

Scope of Biologics Drug Discovery Market Report

Report Metric Details
Report Name Biologics Drug Discovery Market
CAGR 5%
Segment by Type
  • Biologicals
  • Monoclonal Antibodies
  • Recombinant Proteins
  • Other Biologics
Segment by Application
  • Hospitals
  • Clinics
  • Research Labs
  • Diagnostic Centers
  • Others
By Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia) Rest of Europe
  • Nordic Countries
  • Asia-Pacific (China, Japan, South Korea)
  • Southeast Asia (India, Australia)
  • Rest of Asia
  • Latin America (Mexico, Brazil)
  • Rest of Latin America
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company GenScript, Roche, Pfizer, Novartis, Sanofi, Merck, GlaxoSmithKline, AstraZeneca, AbbVie, Amgen, Bristol-Myers Squibb, Novo Nordisk, Allergan, Astellas Pharma, Teva Pharmaceutical Industries
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
  • Chapter 3: Detailed analysis of Biologics Drug Discovery company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
  • Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 12: The main points and conclusions of the report.

FAQ for this report

Who are the main players in the Biologics Drug Discovery Market report?

Ans: The main players in the Biologics Drug Discovery Market are GenScript, Roche, Pfizer, Novartis, Sanofi, Merck, GlaxoSmithKline, AstraZeneca, AbbVie, Amgen, Bristol-Myers Squibb, Novo Nordisk, Allergan, Astellas Pharma, Teva Pharmaceutical Industries

What are the Application segmentation covered in the Biologics Drug Discovery Market report?

Ans: The Applications covered in the Biologics Drug Discovery Market report are Hospitals, Clinics, Research Labs, Diagnostic Centers, Others

What are the Type segmentation covered in the Biologics Drug Discovery Market report?

Ans: The Types covered in the Biologics Drug Discovery Market report are Biologicals, Monoclonal Antibodies, Recombinant Proteins, Other Biologics

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Biologics Drug Discovery Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 Biologicals
1.2.3 Monoclonal Antibodies
1.2.4 Recombinant Proteins
1.2.5 Other Biologics
1.3 Market by Application
1.3.1 Global Biologics Drug Discovery Market Growth by Application: 2020 VS 2024 VS 2031
1.3.2 Hospitals
1.3.3 Clinics
1.3.4 Research Labs
1.3.5 Diagnostic Centers
1.3.6 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Biologics Drug Discovery Market Perspective (2020-2031)
2.2 Global Biologics Drug Discovery Growth Trends by Region
2.2.1 Global Biologics Drug Discovery Market Size by Region: 2020 VS 2024 VS 2031
2.2.2 Biologics Drug Discovery Historic Market Size by Region (2020-2025)
2.2.3 Biologics Drug Discovery Forecasted Market Size by Region (2026-2031)
2.3 Biologics Drug Discovery Market Dynamics
2.3.1 Biologics Drug Discovery Industry Trends
2.3.2 Biologics Drug Discovery Market Drivers
2.3.3 Biologics Drug Discovery Market Challenges
2.3.4 Biologics Drug Discovery Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Biologics Drug Discovery Players by Revenue
3.1.1 Global Top Biologics Drug Discovery Players by Revenue (2020-2025)
3.1.2 Global Biologics Drug Discovery Revenue Market Share by Players (2020-2025)
3.2 Global Biologics Drug Discovery Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by Biologics Drug Discovery Revenue
3.4 Global Biologics Drug Discovery Market Concentration Ratio
3.4.1 Global Biologics Drug Discovery Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Biologics Drug Discovery Revenue in 2024
3.5 Global Key Players of Biologics Drug Discovery Head office and Area Served
3.6 Global Key Players of Biologics Drug Discovery, Product and Application
3.7 Global Key Players of Biologics Drug Discovery, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Biologics Drug Discovery Breakdown Data by Type
4.1 Global Biologics Drug Discovery Historic Market Size by Type (2020-2025)
4.2 Global Biologics Drug Discovery Forecasted Market Size by Type (2026-2031)
5 Biologics Drug Discovery Breakdown Data by Application
5.1 Global Biologics Drug Discovery Historic Market Size by Application (2020-2025)
5.2 Global Biologics Drug Discovery Forecasted Market Size by Application (2026-2031)
6 North America
6.1 North America Biologics Drug Discovery Market Size (2020-2031)
6.2 North America Biologics Drug Discovery Market Growth Rate by Country: 2020 VS 2024 VS 2031
6.3 North America Biologics Drug Discovery Market Size by Country (2020-2025)
6.4 North America Biologics Drug Discovery Market Size by Country (2026-2031)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Biologics Drug Discovery Market Size (2020-2031)
7.2 Europe Biologics Drug Discovery Market Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 Europe Biologics Drug Discovery Market Size by Country (2020-2025)
7.4 Europe Biologics Drug Discovery Market Size by Country (2026-2031)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Biologics Drug Discovery Market Size (2020-2031)
8.2 Asia-Pacific Biologics Drug Discovery Market Growth Rate by Region: 2020 VS 2024 VS 2031
8.3 Asia-Pacific Biologics Drug Discovery Market Size by Region (2020-2025)
8.4 Asia-Pacific Biologics Drug Discovery Market Size by Region (2026-2031)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Biologics Drug Discovery Market Size (2020-2031)
9.2 Latin America Biologics Drug Discovery Market Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Latin America Biologics Drug Discovery Market Size by Country (2020-2025)
9.4 Latin America Biologics Drug Discovery Market Size by Country (2026-2031)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Biologics Drug Discovery Market Size (2020-2031)
10.2 Middle East & Africa Biologics Drug Discovery Market Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 Middle East & Africa Biologics Drug Discovery Market Size by Country (2020-2025)
10.4 Middle East & Africa Biologics Drug Discovery Market Size by Country (2026-2031)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 GenScript
11.1.1 GenScript Company Details
11.1.2 GenScript Business Overview
11.1.3 GenScript Biologics Drug Discovery Introduction
11.1.4 GenScript Revenue in Biologics Drug Discovery Business (2020-2025)
11.1.5 GenScript Recent Development
11.2 Roche
11.2.1 Roche Company Details
11.2.2 Roche Business Overview
11.2.3 Roche Biologics Drug Discovery Introduction
11.2.4 Roche Revenue in Biologics Drug Discovery Business (2020-2025)
11.2.5 Roche Recent Development
11.3 Pfizer
11.3.1 Pfizer Company Details
11.3.2 Pfizer Business Overview
11.3.3 Pfizer Biologics Drug Discovery Introduction
11.3.4 Pfizer Revenue in Biologics Drug Discovery Business (2020-2025)
11.3.5 Pfizer Recent Development
11.4 Novartis
11.4.1 Novartis Company Details
11.4.2 Novartis Business Overview
11.4.3 Novartis Biologics Drug Discovery Introduction
11.4.4 Novartis Revenue in Biologics Drug Discovery Business (2020-2025)
11.4.5 Novartis Recent Development
11.5 Sanofi
11.5.1 Sanofi Company Details
11.5.2 Sanofi Business Overview
11.5.3 Sanofi Biologics Drug Discovery Introduction
11.5.4 Sanofi Revenue in Biologics Drug Discovery Business (2020-2025)
11.5.5 Sanofi Recent Development
11.6 Merck
11.6.1 Merck Company Details
11.6.2 Merck Business Overview
11.6.3 Merck Biologics Drug Discovery Introduction
11.6.4 Merck Revenue in Biologics Drug Discovery Business (2020-2025)
11.6.5 Merck Recent Development
11.7 GlaxoSmithKline
11.7.1 GlaxoSmithKline Company Details
11.7.2 GlaxoSmithKline Business Overview
11.7.3 GlaxoSmithKline Biologics Drug Discovery Introduction
11.7.4 GlaxoSmithKline Revenue in Biologics Drug Discovery Business (2020-2025)
11.7.5 GlaxoSmithKline Recent Development
11.8 AstraZeneca
11.8.1 AstraZeneca Company Details
11.8.2 AstraZeneca Business Overview
11.8.3 AstraZeneca Biologics Drug Discovery Introduction
11.8.4 AstraZeneca Revenue in Biologics Drug Discovery Business (2020-2025)
11.8.5 AstraZeneca Recent Development
11.9 AbbVie
11.9.1 AbbVie Company Details
11.9.2 AbbVie Business Overview
11.9.3 AbbVie Biologics Drug Discovery Introduction
11.9.4 AbbVie Revenue in Biologics Drug Discovery Business (2020-2025)
11.9.5 AbbVie Recent Development
11.10 Amgen
11.10.1 Amgen Company Details
11.10.2 Amgen Business Overview
11.10.3 Amgen Biologics Drug Discovery Introduction
11.10.4 Amgen Revenue in Biologics Drug Discovery Business (2020-2025)
11.10.5 Amgen Recent Development
11.11 Bristol-Myers Squibb
11.11.1 Bristol-Myers Squibb Company Details
11.11.2 Bristol-Myers Squibb Business Overview
11.11.3 Bristol-Myers Squibb Biologics Drug Discovery Introduction
11.11.4 Bristol-Myers Squibb Revenue in Biologics Drug Discovery Business (2020-2025)
11.11.5 Bristol-Myers Squibb Recent Development
11.12 Novo Nordisk
11.12.1 Novo Nordisk Company Details
11.12.2 Novo Nordisk Business Overview
11.12.3 Novo Nordisk Biologics Drug Discovery Introduction
11.12.4 Novo Nordisk Revenue in Biologics Drug Discovery Business (2020-2025)
11.12.5 Novo Nordisk Recent Development
11.13 Allergan
11.13.1 Allergan Company Details
11.13.2 Allergan Business Overview
11.13.3 Allergan Biologics Drug Discovery Introduction
11.13.4 Allergan Revenue in Biologics Drug Discovery Business (2020-2025)
11.13.5 Allergan Recent Development
11.14 Astellas Pharma
11.14.1 Astellas Pharma Company Details
11.14.2 Astellas Pharma Business Overview
11.14.3 Astellas Pharma Biologics Drug Discovery Introduction
11.14.4 Astellas Pharma Revenue in Biologics Drug Discovery Business (2020-2025)
11.14.5 Astellas Pharma Recent Development
11.15 Teva Pharmaceutical Industries
11.15.1 Teva Pharmaceutical Industries Company Details
11.15.2 Teva Pharmaceutical Industries Business Overview
11.15.3 Teva Pharmaceutical Industries Biologics Drug Discovery Introduction
11.15.4 Teva Pharmaceutical Industries Revenue in Biologics Drug Discovery Business (2020-2025)
11.15.5 Teva Pharmaceutical Industries Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
List of Tables
 Table 1. Global Biologics Drug Discovery Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
 Table 2. Key Players of Biologicals
 Table 3. Key Players of Monoclonal Antibodies
 Table 4. Key Players of Recombinant Proteins
 Table 5. Key Players of Other Biologics
 Table 6. Global Biologics Drug Discovery Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
 Table 7. Global Biologics Drug Discovery Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 8. Global Biologics Drug Discovery Market Size by Region (2020-2025) & (US$ Million)
 Table 9. Global Biologics Drug Discovery Market Share by Region (2020-2025)
 Table 10. Global Biologics Drug Discovery Forecasted Market Size by Region (2026-2031) & (US$ Million)
 Table 11. Global Biologics Drug Discovery Market Share by Region (2026-2031)
 Table 12. Biologics Drug Discovery Market Trends
 Table 13. Biologics Drug Discovery Market Drivers
 Table 14. Biologics Drug Discovery Market Challenges
 Table 15. Biologics Drug Discovery Market Restraints
 Table 16. Global Biologics Drug Discovery Revenue by Players (2020-2025) & (US$ Million)
 Table 17. Global Biologics Drug Discovery Market Share by Players (2020-2025)
 Table 18. Global Top Biologics Drug Discovery Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Biologics Drug Discovery as of 2024)
 Table 19. Ranking of Global Top Biologics Drug Discovery Companies by Revenue (US$ Million) in 2024
 Table 20. Global 5 Largest Players Market Share by Biologics Drug Discovery Revenue (CR5 and HHI) & (2020-2025)
 Table 21. Global Key Players of Biologics Drug Discovery, Headquarters and Area Served
 Table 22. Global Key Players of Biologics Drug Discovery, Product and Application
 Table 23. Global Key Players of Biologics Drug Discovery, Date of Enter into This Industry
 Table 24. Mergers & Acquisitions, Expansion Plans
 Table 25. Global Biologics Drug Discovery Market Size by Type (2020-2025) & (US$ Million)
 Table 26. Global Biologics Drug Discovery Revenue Market Share by Type (2020-2025)
 Table 27. Global Biologics Drug Discovery Forecasted Market Size by Type (2026-2031) & (US$ Million)
 Table 28. Global Biologics Drug Discovery Revenue Market Share by Type (2026-2031)
 Table 29. Global Biologics Drug Discovery Market Size by Application (2020-2025) & (US$ Million)
 Table 30. Global Biologics Drug Discovery Revenue Market Share by Application (2020-2025)
 Table 31. Global Biologics Drug Discovery Forecasted Market Size by Application (2026-2031) & (US$ Million)
 Table 32. Global Biologics Drug Discovery Revenue Market Share by Application (2026-2031)
 Table 33. North America Biologics Drug Discovery Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 34. North America Biologics Drug Discovery Market Size by Country (2020-2025) & (US$ Million)
 Table 35. North America Biologics Drug Discovery Market Size by Country (2026-2031) & (US$ Million)
 Table 36. Europe Biologics Drug Discovery Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 37. Europe Biologics Drug Discovery Market Size by Country (2020-2025) & (US$ Million)
 Table 38. Europe Biologics Drug Discovery Market Size by Country (2026-2031) & (US$ Million)
 Table 39. Asia-Pacific Biologics Drug Discovery Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 40. Asia-Pacific Biologics Drug Discovery Market Size by Region (2020-2025) & (US$ Million)
 Table 41. Asia-Pacific Biologics Drug Discovery Market Size by Region (2026-2031) & (US$ Million)
 Table 42. Latin America Biologics Drug Discovery Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 43. Latin America Biologics Drug Discovery Market Size by Country (2020-2025) & (US$ Million)
 Table 44. Latin America Biologics Drug Discovery Market Size by Country (2026-2031) & (US$ Million)
 Table 45. Middle East & Africa Biologics Drug Discovery Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 46. Middle East & Africa Biologics Drug Discovery Market Size by Country (2020-2025) & (US$ Million)
 Table 47. Middle East & Africa Biologics Drug Discovery Market Size by Country (2026-2031) & (US$ Million)
 Table 48. GenScript Company Details
 Table 49. GenScript Business Overview
 Table 50. GenScript Biologics Drug Discovery Product
 Table 51. GenScript Revenue in Biologics Drug Discovery Business (2020-2025) & (US$ Million)
 Table 52. GenScript Recent Development
 Table 53. Roche Company Details
 Table 54. Roche Business Overview
 Table 55. Roche Biologics Drug Discovery Product
 Table 56. Roche Revenue in Biologics Drug Discovery Business (2020-2025) & (US$ Million)
 Table 57. Roche Recent Development
 Table 58. Pfizer Company Details
 Table 59. Pfizer Business Overview
 Table 60. Pfizer Biologics Drug Discovery Product
 Table 61. Pfizer Revenue in Biologics Drug Discovery Business (2020-2025) & (US$ Million)
 Table 62. Pfizer Recent Development
 Table 63. Novartis Company Details
 Table 64. Novartis Business Overview
 Table 65. Novartis Biologics Drug Discovery Product
 Table 66. Novartis Revenue in Biologics Drug Discovery Business (2020-2025) & (US$ Million)
 Table 67. Novartis Recent Development
 Table 68. Sanofi Company Details
 Table 69. Sanofi Business Overview
 Table 70. Sanofi Biologics Drug Discovery Product
 Table 71. Sanofi Revenue in Biologics Drug Discovery Business (2020-2025) & (US$ Million)
 Table 72. Sanofi Recent Development
 Table 73. Merck Company Details
 Table 74. Merck Business Overview
 Table 75. Merck Biologics Drug Discovery Product
 Table 76. Merck Revenue in Biologics Drug Discovery Business (2020-2025) & (US$ Million)
 Table 77. Merck Recent Development
 Table 78. GlaxoSmithKline Company Details
 Table 79. GlaxoSmithKline Business Overview
 Table 80. GlaxoSmithKline Biologics Drug Discovery Product
 Table 81. GlaxoSmithKline Revenue in Biologics Drug Discovery Business (2020-2025) & (US$ Million)
 Table 82. GlaxoSmithKline Recent Development
 Table 83. AstraZeneca Company Details
 Table 84. AstraZeneca Business Overview
 Table 85. AstraZeneca Biologics Drug Discovery Product
 Table 86. AstraZeneca Revenue in Biologics Drug Discovery Business (2020-2025) & (US$ Million)
 Table 87. AstraZeneca Recent Development
 Table 88. AbbVie Company Details
 Table 89. AbbVie Business Overview
 Table 90. AbbVie Biologics Drug Discovery Product
 Table 91. AbbVie Revenue in Biologics Drug Discovery Business (2020-2025) & (US$ Million)
 Table 92. AbbVie Recent Development
 Table 93. Amgen Company Details
 Table 94. Amgen Business Overview
 Table 95. Amgen Biologics Drug Discovery Product
 Table 96. Amgen Revenue in Biologics Drug Discovery Business (2020-2025) & (US$ Million)
 Table 97. Amgen Recent Development
 Table 98. Bristol-Myers Squibb Company Details
 Table 99. Bristol-Myers Squibb Business Overview
 Table 100. Bristol-Myers Squibb Biologics Drug Discovery Product
 Table 101. Bristol-Myers Squibb Revenue in Biologics Drug Discovery Business (2020-2025) & (US$ Million)
 Table 102. Bristol-Myers Squibb Recent Development
 Table 103. Novo Nordisk Company Details
 Table 104. Novo Nordisk Business Overview
 Table 105. Novo Nordisk Biologics Drug Discovery Product
 Table 106. Novo Nordisk Revenue in Biologics Drug Discovery Business (2020-2025) & (US$ Million)
 Table 107. Novo Nordisk Recent Development
 Table 108. Allergan Company Details
 Table 109. Allergan Business Overview
 Table 110. Allergan Biologics Drug Discovery Product
 Table 111. Allergan Revenue in Biologics Drug Discovery Business (2020-2025) & (US$ Million)
 Table 112. Allergan Recent Development
 Table 113. Astellas Pharma Company Details
 Table 114. Astellas Pharma Business Overview
 Table 115. Astellas Pharma Biologics Drug Discovery Product
 Table 116. Astellas Pharma Revenue in Biologics Drug Discovery Business (2020-2025) & (US$ Million)
 Table 117. Astellas Pharma Recent Development
 Table 118. Teva Pharmaceutical Industries Company Details
 Table 119. Teva Pharmaceutical Industries Business Overview
 Table 120. Teva Pharmaceutical Industries Biologics Drug Discovery Product
 Table 121. Teva Pharmaceutical Industries Revenue in Biologics Drug Discovery Business (2020-2025) & (US$ Million)
 Table 122. Teva Pharmaceutical Industries Recent Development
 Table 123. Research Programs/Design for This Report
 Table 124. Key Data Information from Secondary Sources
 Table 125. Key Data Information from Primary Sources
 Table 126. Authors List of This Report


List of Figures
 Figure 1. Biologics Drug Discovery Picture
 Figure 2. Global Biologics Drug Discovery Market Size Comparison by Type (2020-2031) & (US$ Million)
 Figure 3. Global Biologics Drug Discovery Market Share by Type: 2024 VS 2031
 Figure 4. Biologicals Features
 Figure 5. Monoclonal Antibodies Features
 Figure 6. Recombinant Proteins Features
 Figure 7. Other Biologics Features
 Figure 8. Global Biologics Drug Discovery Market Size by Application (2020-2031) & (US$ Million)
 Figure 9. Global Biologics Drug Discovery Market Share by Application: 2024 VS 2031
 Figure 10. Hospitals Case Studies
 Figure 11. Clinics Case Studies
 Figure 12. Research Labs Case Studies
 Figure 13. Diagnostic Centers Case Studies
 Figure 14. Others Case Studies
 Figure 15. Biologics Drug Discovery Report Years Considered
 Figure 16. Global Biologics Drug Discovery Market Size (US$ Million), Year-over-Year: 2020-2031
 Figure 17. Global Biologics Drug Discovery Market Size, (US$ Million), 2020 VS 2024 VS 2031
 Figure 18. Global Biologics Drug Discovery Market Share by Region: 2024 VS 2031
 Figure 19. Global Biologics Drug Discovery Market Share by Players in 2024
 Figure 20. Global Top Biologics Drug Discovery Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Biologics Drug Discovery as of 2024)
 Figure 21. The Top 10 and 5 Players Market Share by Biologics Drug Discovery Revenue in 2024
 Figure 22. North America Biologics Drug Discovery Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 23. North America Biologics Drug Discovery Market Share by Country (2020-2031)
 Figure 24. United States Biologics Drug Discovery Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 25. Canada Biologics Drug Discovery Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 26. Europe Biologics Drug Discovery Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 27. Europe Biologics Drug Discovery Market Share by Country (2020-2031)
 Figure 28. Germany Biologics Drug Discovery Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 29. France Biologics Drug Discovery Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 30. U.K. Biologics Drug Discovery Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 31. Italy Biologics Drug Discovery Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 32. Russia Biologics Drug Discovery Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 33. Nordic Countries Biologics Drug Discovery Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 34. Asia-Pacific Biologics Drug Discovery Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 35. Asia-Pacific Biologics Drug Discovery Market Share by Region (2020-2031)
 Figure 36. China Biologics Drug Discovery Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 37. Japan Biologics Drug Discovery Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 38. South Korea Biologics Drug Discovery Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 39. Southeast Asia Biologics Drug Discovery Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 40. India Biologics Drug Discovery Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 41. Australia Biologics Drug Discovery Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 42. Latin America Biologics Drug Discovery Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 43. Latin America Biologics Drug Discovery Market Share by Country (2020-2031)
 Figure 44. Mexico Biologics Drug Discovery Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 45. Brazil Biologics Drug Discovery Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 46. Middle East & Africa Biologics Drug Discovery Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 47. Middle East & Africa Biologics Drug Discovery Market Share by Country (2020-2031)
 Figure 48. Turkey Biologics Drug Discovery Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 49. Saudi Arabia Biologics Drug Discovery Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 50. UAE Biologics Drug Discovery Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 51. GenScript Revenue Growth Rate in Biologics Drug Discovery Business (2020-2025)
 Figure 52. Roche Revenue Growth Rate in Biologics Drug Discovery Business (2020-2025)
 Figure 53. Pfizer Revenue Growth Rate in Biologics Drug Discovery Business (2020-2025)
 Figure 54. Novartis Revenue Growth Rate in Biologics Drug Discovery Business (2020-2025)
 Figure 55. Sanofi Revenue Growth Rate in Biologics Drug Discovery Business (2020-2025)
 Figure 56. Merck Revenue Growth Rate in Biologics Drug Discovery Business (2020-2025)
 Figure 57. GlaxoSmithKline Revenue Growth Rate in Biologics Drug Discovery Business (2020-2025)
 Figure 58. AstraZeneca Revenue Growth Rate in Biologics Drug Discovery Business (2020-2025)
 Figure 59. AbbVie Revenue Growth Rate in Biologics Drug Discovery Business (2020-2025)
 Figure 60. Amgen Revenue Growth Rate in Biologics Drug Discovery Business (2020-2025)
 Figure 61. Bristol-Myers Squibb Revenue Growth Rate in Biologics Drug Discovery Business (2020-2025)
 Figure 62. Novo Nordisk Revenue Growth Rate in Biologics Drug Discovery Business (2020-2025)
 Figure 63. Allergan Revenue Growth Rate in Biologics Drug Discovery Business (2020-2025)
 Figure 64. Astellas Pharma Revenue Growth Rate in Biologics Drug Discovery Business (2020-2025)
 Figure 65. Teva Pharmaceutical Industries Revenue Growth Rate in Biologics Drug Discovery Business (2020-2025)
 Figure 66. Bottom-up and Top-down Approaches for This Report
 Figure 67. Data Triangulation
 Figure 68. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)

OUR CUSTOMER

Samsung SD

SIMILAR REPORTS

RELATED REPORTS

Global Pharma and Healthcare Social Media Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-14Y6812
Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Global Food Additives Testing Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-34O3983
Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Global Gabapentin API Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-9V17601
Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Global Electronic Informed Consent Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-22C17047
Fri Sep 12 00:00:00 UTC 2025

Add to Cart